Indeed, we found that stage III/IV ovarian cancer patients with high expression of SIK3 are more chemosensitive than patients with low expression of SIK3 (Table 1, P=0.01, Fisher's exact test). The gene discussed is SIK3; the disease is ovarian carcinoma.